Click here to log in.
Search for therapies, clinical trials and demographic information by country and subtype.
A phase 2, open-label, multicentre study
Patients with Hodgkin lymphoma have a high incidence of severe acute and persistent fatigue, regardless of their tumor stage or the treatment method chosen for their disease, according to study
The National Institute of Health Care and Excellence (NICE) has published draft guidance that does not recommend obinutuzumab with bendamustine for treating some people with follicular lymphoma
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.